Conatus Pharmaceuticals Return on Investment 2012-2019 | CNAT
Current and historical return on investment (ROI) values for Conatus Pharmaceuticals (CNAT) over the last 10 years.
| Conatus Pharmaceuticals ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2019-09-30 | $-0.01B | -108.33% | |
| 2019-06-30 | $-0.02B | $0.02B | -76.92% |
| 2019-03-31 | $-0.02B | $0.02B | -86.36% |
| 2018-12-31 | $-0.02B | -75.25% | |
| 2018-09-30 | $-0.02B | $0.03B | -53.52% |
| 2018-06-30 | $-0.02B | $0.03B | -46.15% |
| 2018-03-31 | $-0.02B | $0.04B | -42.60% |
| 2017-12-31 | $-0.02B | $0.04B | -41.46% |
| 2017-09-30 | $-0.02B | $0.04B | -74.80% |
| 2017-06-30 | $-0.03B | $0.05B | -96.30% |
| 2017-03-31 | $-0.03B | $0.03B | -120.00% |
| 2016-12-31 | $-0.03B | -133.33% | |
| 2016-09-30 | $-0.03B | $0.03B | -82.54% |
| 2016-06-30 | $-0.03B | $0.03B | -72.46% |
| 2016-03-31 | $-0.03B | $0.03B | -64.94% |
| 2015-12-31 | $-0.02B | $0.04B | -63.58% |
| 2015-09-30 | $-0.02B | $0.04B | -61.74% |
| 2015-06-30 | $-0.02B | $0.05B | -62.59% |
| 2015-03-31 | $-0.02B | $0.03B | -59.86% |
| 2014-12-31 | $-0.02B | $0.03B | -71.19% |
| 2014-06-30 | $-0.01B | $0.05B | -52.53% |
| 2014-03-31 | $-0.01B | -74.07% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.012B | $0.034B |
| Conatus Pharmaceuticals, Inc. is a biotechnology company. It is focused on developing and commercializing medicines to treat liver disease. The Company is developing its lead compound, emricasan, for the treatment of patients in orphan populations with chronic liver disease and acute exacerbations of chronic liver disease. Conatus Pharmaceuticals, Inc. is headquartered in San Diego, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medtronic (MDT) | Ireland | $151.583B | 20.94 |
| Abbott Laboratories (ABT) | United States | $151.168B | 27.57 |
| Stryker (SYK) | United States | $76.313B | 25.66 |
| Boston Scientific (BSX) | United States | $61.440B | 29.00 |
| Baxter (BAX) | United States | $42.463B | 25.75 |
| Essilor Luxottica (ESLOY) | France | $33.468B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $30.550B | 19.17 |
| Terumo (TRUMY) | Japan | $27.062B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $25.531B | 0.00 |
| Coloplast (CLPBY) | Denmark | $25.294B | 39.03 |
| ResMed (RMD) | United States | $21.653B | 39.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $19.279B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $19.151B | 0.00 |
| Insulet (PODD) | United States | $11.373B | 541.06 |
| Bio-Rad Laboratories (BIO) | United States | $11.201B | 53.76 |
| DiaSorin S.p.A (DSRLF) | Italy | $7.616B | 0.00 |
| William Demant Holdings (WILYY) | Denmark | $7.531B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $7.203B | 21.24 |
| Perrigo (PRGO) | Ireland | $7.117B | 13.27 |
| Canopy Growth (CGC) | Canada | $6.501B | 0.00 |
| Haemonetics (HAE) | United States | $6.146B | 41.53 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $5.743B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $5.276B | 0.00 |
| NuVasive (NUVA) | United States | $3.890B | 30.64 |
| ICU Medical (ICUI) | United States | $3.830B | 24.97 |
| Neogen (NEOG) | United States | $3.545B | 59.33 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $3.165B | 0.00 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.121B | 0.00 |
| Quidel (QDEL) | United States | $2.954B | 28.04 |
| Aurora Cannabis (ACB) | Canada | $2.648B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.432B | 54.89 |
| Agios Pharmaceuticals (AGIO) | United States | $2.411B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.577B | 0.00 |
| InMode (INMD) | Israel | $1.516B | 0.00 |
| AtriCure (ATRC) | United States | $1.226B | 0.00 |
| Aphria (APHA) | $1.187B | 0.00 | |
| VAREX IMAGING (VREX) | United States | $1.162B | 23.28 |
| Phibro Animal Health (PAHC) | United States | $0.994B | 18.61 |
| NanoString Technologies (NSTG) | United States | $0.944B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.802B | 20.04 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.771B | 29.55 |
| TG Therapeutics (TGTX) | United States | $0.709B | 0.00 |
| Quanterix (QTRX) | United States | $0.705B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.698B | 39.25 |
| PetIQ (PETQ) | United States | $0.675B | 16.46 |
| Omeros (OMER) | United States | $0.655B | 0.00 |
| Cerus (CERS) | United States | $0.574B | 0.00 |
| Surmodics (SRDX) | United States | $0.570B | 59.24 |
| HEXO (HEXO) | $0.537B | 0.00 | |
| OraSure Technologies (OSUR) | United States | $0.492B | 29.52 |
| Owens & Minor (OMI) | United States | $0.474B | 17.53 |
| MacroGenics (MGNX) | United States | $0.474B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.405B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.396B | 28.71 |
| Meridian Bioscience (VIVO) | United States | $0.396B | 13.62 |
| BioLife Solutions (BLFS) | United States | $0.331B | 134.92 |
| Zynex (ZYXI) | United States | $0.329B | 37.22 |
| Bovie Medical (APYX) | United States | $0.275B | 0.00 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.269B | 0.00 |
| United Health Products (UEEC) | United States | $0.249B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.242B | 25.52 |
| Vapotherm (VAPO) | United States | $0.227B | 0.00 |
| Repro-Med Systems (KRMD) | United States | $0.195B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.192B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.164B | 0.00 |
| Chimerix (CMRX) | United States | $0.151B | 0.00 |
| Female Health (VERU) | United States | $0.148B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.141B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.128B | 0.00 |
| Fonar (FONR) | United States | $0.128B | 9.03 |
| MTech Acquisition (KERN) | United States | $0.114B | 0.00 |
| United-Guardian (UG) | United States | $0.091B | 23.15 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.080B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.069B | 0.00 |
| Nephros (NEPH) | United States | $0.064B | 0.00 |
| Surface Oncology (SURF) | United States | $0.062B | 0.00 |
| ImmuCell (ICCC) | United States | $0.037B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.024B | 0.00 |
| Senestech (SNES) | United States | $0.017B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.015B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.013B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.006B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.005B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.002B | 0.00 |
